Loading…
Left Ventricular Function in Long-Term Survivors of Childhood Lymphoma
Survivors of childhood lymphoma (CL) have markedly increased risk of developing heart failure. Echocardiographic studies after cardiotoxic treatment have primarily demonstrated left ventricular (LV) systolic dysfunction. In the present study, we hypothesized that longer follow-up and a more comprehe...
Saved in:
Published in: | The American journal of cardiology 2014-08, Vol.114 (3), p.483-490 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c518t-23f487bb55cb5b94f55931f98e77f457408124c8ea924519c27068384c4083613 |
---|---|
cites | cdi_FETCH-LOGICAL-c518t-23f487bb55cb5b94f55931f98e77f457408124c8ea924519c27068384c4083613 |
container_end_page | 490 |
container_issue | 3 |
container_start_page | 483 |
container_title | The American journal of cardiology |
container_volume | 114 |
creator | Christiansen, Jon R., MD Hamre, Hanne, MD, PhD Massey, Richard, MSc Dalen, Håvard, MD, PhD Beitnes, Jan O., MD, PhD Fosså, Sophie D., MD, PhD Kiserud, Cecilie E., MD, PhD Aakhus, Svend, MD, PhD |
description | Survivors of childhood lymphoma (CL) have markedly increased risk of developing heart failure. Echocardiographic studies after cardiotoxic treatment have primarily demonstrated left ventricular (LV) systolic dysfunction. In the present study, we hypothesized that longer follow-up and a more comprehensive echocardiographic examination would reveal more cardiac abnormalities. We conducted a cross-sectional study with echocardiography 20.4 ± 8.6 years after diagnosis in 125 survivors of CL, grouped according to treatment methods, and compared with matched controls. Treatment included mediastinal radiotherapy (median 40.0 Gy) in 66 and anthracyclines (median dose 160 mg/m2 ) in 92 survivors of CL. Abnormal LV function, left-sided valve dysfunction, or both occurred in 62 patients (50%). Diastolic dysfunction occurred in 29%. Compared with control subjects, mitral annular early diastolic velocities (e′) were reduced in patients (septal e′ 0.09 ± 0.03 vs 0.12 ± 0.03 m/s, p |
doi_str_mv | 10.1016/j.amjcard.2014.04.055 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_1544415545</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0002914914011345</els_id><sourcerecordid>3369120311</sourcerecordid><originalsourceid>FETCH-LOGICAL-c518t-23f487bb55cb5b94f55931f98e77f457408124c8ea924519c27068384c4083613</originalsourceid><addsrcrecordid>eNqFUV1r3DAQFKWhuSb9CS2GPvuilVdn6aUhHLkmYMhDPl6FLcs9ubZ1leyD-_eRuWsLeQksLMvOzjIzhHwFugQKq6t2WfatLn29ZBRwSWNx_oEsQOQyBQnZR7KglLJUAspz8jmENo4AfPWJnDOUKFCyBdkUphmTFzOM3uqpK32ymQY9WjckdkgKN_xKn4zvk8fJ7-3e-ZC4JllvbVdvnauT4tDvtq4vL8lZU3bBfDn1C_K8uX1a36XFw8_79U2Rag5iTFnWoMirinNd8Upiw7nMoJHC5HmDPEcqgKEWppQMOUjNcroSmUAdN9kKsgvy_ci78-7PZMKoWjf5Ib5UwBEROEceUfyI0t6F4E2jdt72pT8ooGp2T7Xq5J6a3VM0Fp_vvp3Yp6o39b-rv3ZFwPURYKLGvTVeBW3NoE1tvdGjqp1998WPNwy6s4PVZffbHEz4r0YFpqh6nCOcEwSM2WVR2yvcpZVX</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1544415545</pqid></control><display><type>article</type><title>Left Ventricular Function in Long-Term Survivors of Childhood Lymphoma</title><source>ScienceDirect Freedom Collection</source><creator>Christiansen, Jon R., MD ; Hamre, Hanne, MD, PhD ; Massey, Richard, MSc ; Dalen, Håvard, MD, PhD ; Beitnes, Jan O., MD, PhD ; Fosså, Sophie D., MD, PhD ; Kiserud, Cecilie E., MD, PhD ; Aakhus, Svend, MD, PhD</creator><creatorcontrib>Christiansen, Jon R., MD ; Hamre, Hanne, MD, PhD ; Massey, Richard, MSc ; Dalen, Håvard, MD, PhD ; Beitnes, Jan O., MD, PhD ; Fosså, Sophie D., MD, PhD ; Kiserud, Cecilie E., MD, PhD ; Aakhus, Svend, MD, PhD</creatorcontrib><description>Survivors of childhood lymphoma (CL) have markedly increased risk of developing heart failure. Echocardiographic studies after cardiotoxic treatment have primarily demonstrated left ventricular (LV) systolic dysfunction. In the present study, we hypothesized that longer follow-up and a more comprehensive echocardiographic examination would reveal more cardiac abnormalities. We conducted a cross-sectional study with echocardiography 20.4 ± 8.6 years after diagnosis in 125 survivors of CL, grouped according to treatment methods, and compared with matched controls. Treatment included mediastinal radiotherapy (median 40.0 Gy) in 66 and anthracyclines (median dose 160 mg/m2 ) in 92 survivors of CL. Abnormal LV function, left-sided valve dysfunction, or both occurred in 62 patients (50%). Diastolic dysfunction occurred in 29%. Compared with control subjects, mitral annular early diastolic velocities (e′) were reduced in patients (septal e′ 0.09 ± 0.03 vs 0.12 ± 0.03 m/s, p <0.001), and the E/e′ ratio was increased, particularly after mediastinal radiotherapy (10.6 ± 6.4 vs 5.6 ± 1.3, p <0.001). Survivors of CL had lower fractional shortening than control subjects (32 ± 6 vs 36 ± 7, p <0.001), but mean ejection fraction was equal and overt systolic dysfunction was infrequent. After mediastinal radiotherapy alone, global longitudinal myocardial strain was lower (p <0.05) compared with other treatment groups. Left-sided valvular dysfunction occurred in 55% of patients after mediastinal radiotherapy. In conclusion, survivors of CL had reduced LV diastolic function assessed by tissue Doppler imaging. This was more pronounced after mediastinal radiotherapy, which also frequently led to valvular disease. Systolic function was normal in most survivors of CL.</description><identifier>ISSN: 0002-9149</identifier><identifier>EISSN: 1879-1913</identifier><identifier>DOI: 10.1016/j.amjcard.2014.04.055</identifier><identifier>PMID: 24948492</identifier><identifier>CODEN: AJCDAG</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Adolescent ; Adult ; Age ; Cardiology ; Cardiovascular ; Child ; Drug therapy ; Echocardiography ; Female ; Forecasting ; Humans ; Lymphoma - diagnostic imaging ; Lymphoma - mortality ; Lymphoma - physiopathology ; Male ; Medical research ; Methods ; Middle Aged ; Norway - epidemiology ; Radiation therapy ; Registries ; Retrospective Studies ; Studies ; Surveys and Questionnaires ; Survival Rate - trends ; Survivors - statistics & numerical data ; Veins & arteries ; Ventricular Function, Left - physiology ; Young Adult</subject><ispartof>The American journal of cardiology, 2014-08, Vol.114 (3), p.483-490</ispartof><rights>Elsevier Inc.</rights><rights>2014 Elsevier Inc.</rights><rights>Copyright © 2014 Elsevier Inc. All rights reserved.</rights><rights>Copyright Elsevier Limited Aug 1, 2014</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c518t-23f487bb55cb5b94f55931f98e77f457408124c8ea924519c27068384c4083613</citedby><cites>FETCH-LOGICAL-c518t-23f487bb55cb5b94f55931f98e77f457408124c8ea924519c27068384c4083613</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24948492$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Christiansen, Jon R., MD</creatorcontrib><creatorcontrib>Hamre, Hanne, MD, PhD</creatorcontrib><creatorcontrib>Massey, Richard, MSc</creatorcontrib><creatorcontrib>Dalen, Håvard, MD, PhD</creatorcontrib><creatorcontrib>Beitnes, Jan O., MD, PhD</creatorcontrib><creatorcontrib>Fosså, Sophie D., MD, PhD</creatorcontrib><creatorcontrib>Kiserud, Cecilie E., MD, PhD</creatorcontrib><creatorcontrib>Aakhus, Svend, MD, PhD</creatorcontrib><title>Left Ventricular Function in Long-Term Survivors of Childhood Lymphoma</title><title>The American journal of cardiology</title><addtitle>Am J Cardiol</addtitle><description>Survivors of childhood lymphoma (CL) have markedly increased risk of developing heart failure. Echocardiographic studies after cardiotoxic treatment have primarily demonstrated left ventricular (LV) systolic dysfunction. In the present study, we hypothesized that longer follow-up and a more comprehensive echocardiographic examination would reveal more cardiac abnormalities. We conducted a cross-sectional study with echocardiography 20.4 ± 8.6 years after diagnosis in 125 survivors of CL, grouped according to treatment methods, and compared with matched controls. Treatment included mediastinal radiotherapy (median 40.0 Gy) in 66 and anthracyclines (median dose 160 mg/m2 ) in 92 survivors of CL. Abnormal LV function, left-sided valve dysfunction, or both occurred in 62 patients (50%). Diastolic dysfunction occurred in 29%. Compared with control subjects, mitral annular early diastolic velocities (e′) were reduced in patients (septal e′ 0.09 ± 0.03 vs 0.12 ± 0.03 m/s, p <0.001), and the E/e′ ratio was increased, particularly after mediastinal radiotherapy (10.6 ± 6.4 vs 5.6 ± 1.3, p <0.001). Survivors of CL had lower fractional shortening than control subjects (32 ± 6 vs 36 ± 7, p <0.001), but mean ejection fraction was equal and overt systolic dysfunction was infrequent. After mediastinal radiotherapy alone, global longitudinal myocardial strain was lower (p <0.05) compared with other treatment groups. Left-sided valvular dysfunction occurred in 55% of patients after mediastinal radiotherapy. In conclusion, survivors of CL had reduced LV diastolic function assessed by tissue Doppler imaging. This was more pronounced after mediastinal radiotherapy, which also frequently led to valvular disease. Systolic function was normal in most survivors of CL.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Age</subject><subject>Cardiology</subject><subject>Cardiovascular</subject><subject>Child</subject><subject>Drug therapy</subject><subject>Echocardiography</subject><subject>Female</subject><subject>Forecasting</subject><subject>Humans</subject><subject>Lymphoma - diagnostic imaging</subject><subject>Lymphoma - mortality</subject><subject>Lymphoma - physiopathology</subject><subject>Male</subject><subject>Medical research</subject><subject>Methods</subject><subject>Middle Aged</subject><subject>Norway - epidemiology</subject><subject>Radiation therapy</subject><subject>Registries</subject><subject>Retrospective Studies</subject><subject>Studies</subject><subject>Surveys and Questionnaires</subject><subject>Survival Rate - trends</subject><subject>Survivors - statistics & numerical data</subject><subject>Veins & arteries</subject><subject>Ventricular Function, Left - physiology</subject><subject>Young Adult</subject><issn>0002-9149</issn><issn>1879-1913</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><recordid>eNqFUV1r3DAQFKWhuSb9CS2GPvuilVdn6aUhHLkmYMhDPl6FLcs9ubZ1leyD-_eRuWsLeQksLMvOzjIzhHwFugQKq6t2WfatLn29ZBRwSWNx_oEsQOQyBQnZR7KglLJUAspz8jmENo4AfPWJnDOUKFCyBdkUphmTFzOM3uqpK32ymQY9WjckdkgKN_xKn4zvk8fJ7-3e-ZC4JllvbVdvnauT4tDvtq4vL8lZU3bBfDn1C_K8uX1a36XFw8_79U2Rag5iTFnWoMirinNd8Upiw7nMoJHC5HmDPEcqgKEWppQMOUjNcroSmUAdN9kKsgvy_ci78-7PZMKoWjf5Ib5UwBEROEceUfyI0t6F4E2jdt72pT8ooGp2T7Xq5J6a3VM0Fp_vvp3Yp6o39b-rv3ZFwPURYKLGvTVeBW3NoE1tvdGjqp1998WPNwy6s4PVZffbHEz4r0YFpqh6nCOcEwSM2WVR2yvcpZVX</recordid><startdate>20140801</startdate><enddate>20140801</enddate><creator>Christiansen, Jon R., MD</creator><creator>Hamre, Hanne, MD, PhD</creator><creator>Massey, Richard, MSc</creator><creator>Dalen, Håvard, MD, PhD</creator><creator>Beitnes, Jan O., MD, PhD</creator><creator>Fosså, Sophie D., MD, PhD</creator><creator>Kiserud, Cecilie E., MD, PhD</creator><creator>Aakhus, Svend, MD, PhD</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7TS</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>M7Z</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope></search><sort><creationdate>20140801</creationdate><title>Left Ventricular Function in Long-Term Survivors of Childhood Lymphoma</title><author>Christiansen, Jon R., MD ; Hamre, Hanne, MD, PhD ; Massey, Richard, MSc ; Dalen, Håvard, MD, PhD ; Beitnes, Jan O., MD, PhD ; Fosså, Sophie D., MD, PhD ; Kiserud, Cecilie E., MD, PhD ; Aakhus, Svend, MD, PhD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c518t-23f487bb55cb5b94f55931f98e77f457408124c8ea924519c27068384c4083613</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Age</topic><topic>Cardiology</topic><topic>Cardiovascular</topic><topic>Child</topic><topic>Drug therapy</topic><topic>Echocardiography</topic><topic>Female</topic><topic>Forecasting</topic><topic>Humans</topic><topic>Lymphoma - diagnostic imaging</topic><topic>Lymphoma - mortality</topic><topic>Lymphoma - physiopathology</topic><topic>Male</topic><topic>Medical research</topic><topic>Methods</topic><topic>Middle Aged</topic><topic>Norway - epidemiology</topic><topic>Radiation therapy</topic><topic>Registries</topic><topic>Retrospective Studies</topic><topic>Studies</topic><topic>Surveys and Questionnaires</topic><topic>Survival Rate - trends</topic><topic>Survivors - statistics & numerical data</topic><topic>Veins & arteries</topic><topic>Ventricular Function, Left - physiology</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Christiansen, Jon R., MD</creatorcontrib><creatorcontrib>Hamre, Hanne, MD, PhD</creatorcontrib><creatorcontrib>Massey, Richard, MSc</creatorcontrib><creatorcontrib>Dalen, Håvard, MD, PhD</creatorcontrib><creatorcontrib>Beitnes, Jan O., MD, PhD</creatorcontrib><creatorcontrib>Fosså, Sophie D., MD, PhD</creatorcontrib><creatorcontrib>Kiserud, Cecilie E., MD, PhD</creatorcontrib><creatorcontrib>Aakhus, Svend, MD, PhD</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Nursing & Allied Health Database</collection><collection>Physical Education Index</collection><collection>ProQuest - Health & Medical Complete保健、医学与药学数据库</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>ProQuest research library</collection><collection>Biochemistry Abstracts 1</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><jtitle>The American journal of cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Christiansen, Jon R., MD</au><au>Hamre, Hanne, MD, PhD</au><au>Massey, Richard, MSc</au><au>Dalen, Håvard, MD, PhD</au><au>Beitnes, Jan O., MD, PhD</au><au>Fosså, Sophie D., MD, PhD</au><au>Kiserud, Cecilie E., MD, PhD</au><au>Aakhus, Svend, MD, PhD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Left Ventricular Function in Long-Term Survivors of Childhood Lymphoma</atitle><jtitle>The American journal of cardiology</jtitle><addtitle>Am J Cardiol</addtitle><date>2014-08-01</date><risdate>2014</risdate><volume>114</volume><issue>3</issue><spage>483</spage><epage>490</epage><pages>483-490</pages><issn>0002-9149</issn><eissn>1879-1913</eissn><coden>AJCDAG</coden><abstract>Survivors of childhood lymphoma (CL) have markedly increased risk of developing heart failure. Echocardiographic studies after cardiotoxic treatment have primarily demonstrated left ventricular (LV) systolic dysfunction. In the present study, we hypothesized that longer follow-up and a more comprehensive echocardiographic examination would reveal more cardiac abnormalities. We conducted a cross-sectional study with echocardiography 20.4 ± 8.6 years after diagnosis in 125 survivors of CL, grouped according to treatment methods, and compared with matched controls. Treatment included mediastinal radiotherapy (median 40.0 Gy) in 66 and anthracyclines (median dose 160 mg/m2 ) in 92 survivors of CL. Abnormal LV function, left-sided valve dysfunction, or both occurred in 62 patients (50%). Diastolic dysfunction occurred in 29%. Compared with control subjects, mitral annular early diastolic velocities (e′) were reduced in patients (septal e′ 0.09 ± 0.03 vs 0.12 ± 0.03 m/s, p <0.001), and the E/e′ ratio was increased, particularly after mediastinal radiotherapy (10.6 ± 6.4 vs 5.6 ± 1.3, p <0.001). Survivors of CL had lower fractional shortening than control subjects (32 ± 6 vs 36 ± 7, p <0.001), but mean ejection fraction was equal and overt systolic dysfunction was infrequent. After mediastinal radiotherapy alone, global longitudinal myocardial strain was lower (p <0.05) compared with other treatment groups. Left-sided valvular dysfunction occurred in 55% of patients after mediastinal radiotherapy. In conclusion, survivors of CL had reduced LV diastolic function assessed by tissue Doppler imaging. This was more pronounced after mediastinal radiotherapy, which also frequently led to valvular disease. Systolic function was normal in most survivors of CL.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>24948492</pmid><doi>10.1016/j.amjcard.2014.04.055</doi><tpages>8</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0002-9149 |
ispartof | The American journal of cardiology, 2014-08, Vol.114 (3), p.483-490 |
issn | 0002-9149 1879-1913 |
language | eng |
recordid | cdi_proquest_journals_1544415545 |
source | ScienceDirect Freedom Collection |
subjects | Adolescent Adult Age Cardiology Cardiovascular Child Drug therapy Echocardiography Female Forecasting Humans Lymphoma - diagnostic imaging Lymphoma - mortality Lymphoma - physiopathology Male Medical research Methods Middle Aged Norway - epidemiology Radiation therapy Registries Retrospective Studies Studies Surveys and Questionnaires Survival Rate - trends Survivors - statistics & numerical data Veins & arteries Ventricular Function, Left - physiology Young Adult |
title | Left Ventricular Function in Long-Term Survivors of Childhood Lymphoma |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T06%3A02%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Left%20Ventricular%20Function%20in%20Long-Term%20Survivors%20of%20Childhood%20Lymphoma&rft.jtitle=The%20American%20journal%20of%20cardiology&rft.au=Christiansen,%20Jon%20R.,%20MD&rft.date=2014-08-01&rft.volume=114&rft.issue=3&rft.spage=483&rft.epage=490&rft.pages=483-490&rft.issn=0002-9149&rft.eissn=1879-1913&rft.coden=AJCDAG&rft_id=info:doi/10.1016/j.amjcard.2014.04.055&rft_dat=%3Cproquest_cross%3E3369120311%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c518t-23f487bb55cb5b94f55931f98e77f457408124c8ea924519c27068384c4083613%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1544415545&rft_id=info:pmid/24948492&rfr_iscdi=true |